Optiscan Imaging Limited engages in the development, manufacture, and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Price analytics
Returns
1 day
3.1%
1 week
26.9%
1 month
13.8%
3 months
10.0%
6 months
65.0%
1 year
32.0%
3 years
126.0%
Risk
Volatility (1y ann.)
78.4%
Beta vs ASX 200
0.13
Sharpe (1y)
0.69
VaR 95% (1-day)
-7.4%
Max drawdown (1y)
-40.0%
Off 1-year high
-15.4%
Technicals
RSI(14)
53
vs 50DMA
6.5%
vs 200DMA
37.5%
Trend
Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value39.6
Trailing P/E
—
Forward P/E
—
PEG ratio
24
EV / EBITDA
100
Price / Book
0
Price / Sales
0
Growth0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum90.1
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
82
Position in 52-week range
71
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).